COVID-19 IgM / IgG Impande Zitemba
Kumenyekanisha ibicuruzwa
Virusee® COVID-19 IgM / IgG Lateral Flow Assay ni immunoassay itembera ikoreshwa mugukoresha vitro yujuje ubuziranenge bwa coronavirus (SARS-CoV-2) antibodiyite IgM / IgG mumitsi yabantu mumaraso yose, plasma, na serumu.
Igitabo coronavirus ni virusi nziza ya RNA imwe.Bitandukanye na coronavirus izwi, abaturage bugarijwe na Novel Coronavirus muri rusange barashobora kwibasirwa, kandi birabangamira cyane abasaza cyangwa abantu bafite uburwayi bwibanze.Antibodies nziza ya IgM / IgG ni ikimenyetso cyingenzi cyerekana ubwandu bwa coronavirus.Kumenya antibodiyite yihariye ya coronavirus bizafasha kwisuzumisha kwa muganga.
Ibiranga
| Izina | COVID-19 IgM / IgG Impande Zitemba |
| Uburyo | Uruhande rutemba |
| Ubwoko bw'icyitegererezo | Amaraso, plasma, serumu |
| Ibisobanuro | Ibizamini 20 / kit |
| Igihe cyo kumenya | Imin. 10 |
| Ibintu byo gutahura | COVID-19 |
| Igihagararo | Igikoresho gihamye kumwaka 1 kuri 2-30 ° C. |
Ibyiza
- Byihuta
Shaka ibisubizo mu minota 10 - Biroroshye
Biboneka gusoma ibisubizo, byoroshye kubisobanura
Inzira yoroshye, idafite imikorere igoye
- Kuzigama
Ibicuruzwa birashobora gutwarwa no kubikwa mubushyuhe bwicyumba, kugabanya ibiciro - Ibyago bike
Gupima icyitegererezo cyamaraso, kugabanya ibyago byo gutorwa - Birakwiye kwerekanwa kurubuga, kuryama, hanze
Amavu n'amavuko
Igitabo cyitwa coronavirus, syndrome de acute respiratory syndrome coronavirus (SARS-CoV) -2, cyagaragaye ko ari cyo gitera indwara ya coronavirus 2019 (COVID-19).Iyi ndwara yiswe ibyihutirwa by’ubuzima rusange by’umuryango mpuzamahanga wita ku buzima (OMS).
COVID-19 yibasira sisitemu yubuhumekero yo hejuru no hepfo kandi itera ibimenyetso nkibicurane kubantu benshi banduye.Nubwo abarwayi benshi ba COVID-19 bafite ibimenyetso byoroheje gusa, abarwayi bamwe bafite ibimenyetso bikomeye biganisha ku bihaha bikabije.Uburyo bwo kuvura COVID-19 ni buke kandi igipimo cy’imfu ziterwa na OMS kiri hafi 2.9%.Nubwo urukingo rwo kwirinda COVID-19 amaherezo rushobora kuboneka, keretse niba ubudahangarwa bw’amashyo buhagije bwagerwaho, COVID-19 irashobora guteza indwara n’impfu zikomeye mu myaka iri imbere.
Nyuma yo kwandura indwara, birasanzwe ko habaho antibody irwanya indwara runaka.Kera nyuma yo kwandura (mubisanzwe nyuma yicyumweru cya mbere), itsinda rya antibodies zizwi nka immunoglobuline M (IgM) riratera imbere, nubwo mubisanzwe bitaramba.Nyuma, nyuma yibyumweru 2-4 byambere bikurikira kwandura, IgG, antibody iramba cyane.
Ubushakashatsi bwerekanye ko antibodiyite yibasiwe na RBD ari ibimenyetso byiza byanduye byabanje kandi biheruka, ko gupima isotype itandukanye bishobora gufasha gutandukanya indwara ziherutse kandi zishaje.Kumenya antibodiyite za IgM na IgG zirwanya SARS-CoV-2 bifite akamaro kanini mugusuzuma uburemere no guhanura COVID-19, ndetse bikongerera kumenya neza ibizamini bya aside nucleaire.
Kumenya SARS-CoV-2 IgM na IgG ni ngombwa cyane kugirango umenye inzira ya COVID-19.Kumenya aside nucleique ifatanije na antibody ya serumu ya SARS-CoV-2 irashobora kuba ikimenyetso cyiza cya laboratoire yo gusuzuma indwara ya SARS-CoV-2 hamwe ninteruro no guhanura ibizaba COVID-19.
Inzira y'ibizamini
Tegeka amakuru
| Icyitegererezo | Ibisobanuro | Kode y'ibicuruzwa |
| VMGLFA-01 | 20 ikizamini / ibikoresho, imiterere ya cassette | CoVMGLFA-01 |
